Bozic Carmen sold VRTX
May 29, 2024 · Form 4 insider transaction
Bozic Carmen sold 2,280 shares of Vertex Pharmaceuticals Incorporated at $445.56 per share, a transaction worth $1.02M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,280
Price
$445.56
Total value
$1.02M
InsiderBozic Carmen
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 29, 2024
Filing dateMay 31, 2024
Shares owned after34,659
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024.